Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1031 596
Brodalumab 399 0
Certolizumab 129 0
Efalizumab 35 0
Etanercept 309 64
Golimumab 25 0
Guselkumab 850 0
Infliximab 101 1
Ixekizumab 643 0
Risankizumab 514 0
Secukinumab 1482 0
Tildrakizumab 579 0
Ustekinumab 737 0
Apremilast 599 0
Ciclosporin 399 0
Fumaderm 2667 0
Skilarence 2380 0
Methotrexate 3733 0
Tofacitinib 2 0
other systemics 348 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers